Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Nanopore Technologies Regulatory News (ONT)

Share Price Information for Oxford Nanopore Technologies (ONT)

Share Price is delayed by 15 minutes
Get Live Data
130.90    0.60 (0.46%)
Bid:
130.90
Ask:
133.00
Spread: 2.10 (1.604%)
Market Cap: £1.27b
ONT Live PriceLast checked at - London Stock Exchange

Intraday Oxford Nanopore Technologies Share Chart

SIP PDMR Notification - Correction

14 Mar 2025 15:00

RNS Number : 7891A
Oxford Nanopore Technologies plc
14 March 2025
 

14 March 2025

Oxford Nanopore Technologies plc (the "Company")

GENERAL CORRECTION

The following amendment has been made to the 'PDMR Notification' announcement released on 13 March 2025 at 15:00 under RNS No: 5980A.

The headline of the announcement has been amended to remove the wording 'and correction to previous PDMR Notification'. This was included erroneously and no corrections were due to be made in the announcement.

All other details remain unchanged. The full amended text is shown below.

 

Share Incentive Plan ("SIP") PDMR Notification

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The Company has been notified by Computershare Trustees Limited, the trustee of the SIP (the "SIP Trustee") that on 12 March 2025, it made an award of Partnership Shares (as defined in the SIP) of 150 ordinary shares of £0.0001 ("Ordinary Shares") on behalf of Nick Keher, a director of the Company and a Person Discharging Managerial Responsibilities ("PDMR"). The Ordinary Shares were purchased using each participating employee's gross salary at a price of £1.00 per Ordinary Share.

Under the SIP, the SIP Trustee will award each participating employee one Matching Share (as defined in the SIP) for each Ordinary Share purchased by the employee under the SIP. On 12 March 2025, the Company issued 150 Ordinary Shares to the SIP Trustee to hold on behalf of Nick Keher to satisfy the Matching Shares awarded under the SIP to him on that date.

Further details of the transactions referred to above by the SIP Trustee are set out below:

Name of PDMR

Number of Partnership Shares

Number of Matching Shares

Nick Keher (Director)

150

150

 

This announcement is made pursuant to the Company's obligations under Article 19(3) of the UK Market Abuse Regulation.

Nick Keher - purchase of shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nick Keher

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Purchase of Ordinary Shares under the SIP, held through the SIP Trustee.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£1.00

150

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

150 shares

£150.00

e)

Date of the transaction

12 March 2025

f)

Place of the transaction

London Stock Exchange (XLON)

 

Nick Keher - issue of new shares under the SIP

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nick Keher

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial/Amendment notification

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Oxford Nanopore Technologies plc

b)

LEI

213800IRWQ2Q6M2CDW55

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 Ordinary shares of £0.0001 each

 

 

GB00BP6S8Z30

b)

Nature of the transaction

Grant of Matching Shares through an issue of Ordinary Shares under the SIP, held through the SIP Trustee

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

150

d)

Aggregated information

- Aggregated volume

- Aggregated price

 

150 shares

Nil

e)

Date of the transaction

12 March 2025

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

Enquiries:

Investors

ir@nanoporetech.com 

Media 

media@nanoporetech.com

OxfordNanoporeTechnologies@teneo.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFSVVFISLIE
Date   Source Headline
12th Jun 20237:00 amRNSNational German rare disease study
9th Jun 20237:00 amRNSChange of Broker
1st Jun 20233:00 pmRNSIssue of Equity and Total Voting Rights
19th May 20237:00 amRNSLondon Calling Technology Update
12th May 20231:30 pmRNSHolding(s) in Company
12th May 20238:35 amRNSNext step of PathoQuest strategic collaboration
11th May 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Notification
2nd May 20233:00 pmRNSIssue of Equity and Total Voting Rights
26th Apr 20237:00 amRNSPublication of Annual Report and Notice of AGM
17th Apr 20237:00 amRNSNew infectious disease partnership with bioMerieux
13th Apr 20236:00 pmRNSDirector/PDMR Shareholding
12th Apr 20234:00 pmRNSLTIP and DBP; Director/PDMR Notification
12th Apr 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
11th Apr 20237:00 amRNSNIH Alzheimers study shows scaled, accurate data
6th Apr 20234:00 pmRNSBlock listing Interim Review
3rd Apr 20233:30 pmRNSIssue of Equity and Total Voting Rights
31st Mar 20237:00 amRNSNIHR, Oxford Nanopore announce new health study
21st Mar 20237:00 amRNSFinal results for the year ended 31 December 2022
13th Mar 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
9th Mar 20237:00 amRNSNotice of Results
1st Mar 20233:30 pmRNSIssue of Equity and Total Voting Rights
27th Feb 20236:00 pmRNSChanges to Director Roles and Responsibilities
13th Feb 20235:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Feb 20234:30 pmRNSTotal Voting Rights and Issue of Equity
17th Jan 20237:00 amRNSTrading update
13th Jan 20233:30 pmRNSDirector/PDMR Shareholding (ESPP)
11th Jan 20234:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
4th Jan 20235:30 pmRNSDirector/PDMR Shareholding (ESPP)
3rd Jan 20235:00 pmRNSIssue of equity and Total Voting Rights
28th Dec 20223:00 pmRNSHolding(s) in Company
23rd Dec 202212:00 pmRNSHolding(s) in Company
13th Dec 20224:50 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Dec 20223:00 pmRNSIssue of Equity and Total Voting Rights
11th Nov 20224:30 pmRNSDirector/PDMR Shareholding
11th Nov 20224:30 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Nov 20225:00 pmRNSIssue of Equity and Total Voting Rights
11th Oct 20224:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
10th Oct 202212:00 pmRNSDirector/PDMR Shareholding
6th Oct 20225:30 pmRNSBlock listing Interim Review
3rd Oct 20225:00 pmRNSIssue of Equity and Total Voting Rights
29th Sep 20229:00 amRNSDirector/PDMR Shareholding
14th Sep 202211:00 amRNSDirector/PDMR Shareholding
13th Sep 20225:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
13th Sep 20227:00 amRNSInterim results for the period ended 30 June 2022
12th Sep 20224:30 pmRNSOxford Nanopore to present at upcoming conferences
1st Sep 20226:30 pmRNSIssue of Equity and Total Voting Rights
24th Aug 20227:00 amRNSNotice of Results
11th Aug 20224:00 pmRNSShare Incentive Plan - Director/PDMR Shareholding
1st Aug 20225:30 pmRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.